Topics Contents of page 2025 2024 2025 May 8 : Notice of Changes in Executive Officers[PDF 0.11MB] May 8 : Notice Concerning Dividends from Surplus (Increase)[PDF 0.17MB] 2024 June 19, 2024 : Zeria Pharmaceutical and Agastra-Lab announces reaching Agreement for the Development and Market Access of Acotiamide as a Functional Dyspepsia Treatment in Europe, the United States, and Canada[PDF 0.14MB]
